tm logo
DANYELZA NAXITAMAB
REGISTERED

on 15 Sep 2021

Last Applicant/ Owned by

Y-MABS THERAPEUTICS INC

230 Park Avenue,Suite 3350 New YorkNew York NY 10169

US

Serial Number

2015620 filed on 08th Jan 2020

Registration Number

TMA1109494 registered on 15th Sep 2021

Registration expiry Date

08th Jan 2030

Correspondent Address

213-304 Old Canmore RoadCanmore

ALBERTA

CA

T1W0L5

DANYELZA NAXITAMAB

Vienna Information


24 . 17 . 20

Check signsCoches, signes de validation

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 7

Letters surmounted by a sign of disproportionate size -- Note: Includes, for instance, a letter i surmounted by a disproportionate dot, by a star or a flower.Lettres surmontées d'un signe de dimension disproportionnée -- Note: Comprend par exemple la lettre i surmontée d'un point disproportionné, d'une étoile ou d'une fleur.

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

29 . 1 . 4

BlueBleu

29 . 1 . 3

GreenVert

29 . 1 . 5

VioletViolet

Trademark usage description

pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer. rese Read More

Classification Information


Class [005]
Pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer.


Classification kind code

11

Class [042]
Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis in the field of the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of oncology, chemotherapy, and inflammatory diseases; industrial analysis and research services in the field of chemistry.


Classification kind code

11

Mark Details


Serial Number

2015620

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 19th Mar 2021
Agent Changed
Submitted for opposition 256
on 05th Jan 2021
Notification of Possible Opposition Sent
Submitted for opposition 22
on 11th Dec 2020
Search Recorded
Submitted for opposition 20
on 11th Dec 2020
Examiner's First Report
Submitted for opposition 223
on 11th Dec 2020
Total Provisional Refusal
Submitted for opposition 257
on 05th Mar 2020
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 04th Mar 2020
Formalized
Submitted for opposition 1
on 04th Mar 2020
Created
Submitted for opposition 228
on 08th Jan 2020
International Registration
Submitted for opposition 30
on 08th Jan 2020
Filed